MAXCEED CAPITAL GROUP
MAXCEED Capital Group
明 越 資 本
Fund Size: $ 36 M USD
Investment Amount: Opening investment of 0.5 to $1.5 million per venture will be made at early stage with subsequent stage investments made to align with each venture’s progress, up to a total of $5 million per venture over its life.
Structure: We are multi-family office, with each partner’s minimum personal or family asset of 30M. Our investment partners focus on South-East Asia companies and all sorts of equity investments.
There are 12 of us. Our family businesses/ background support us with knowledge, fund, connections and pragmatic ways to build a lucrative business.
1. We co-invest.
2. We invest in companies that may be invested or acquired by our family business or affiliated corporations or PE funds.
3. B2B preferred.
Our mentors come across banking, VC Funds, PE Funds and listed companies.
We look forward to making good friends along this journey.
1. We focus on (but not limited to) Bio-medical & Auto-mobility & Fintech industries.
2. We are open to all good deals referred by our partners (LP).
Introduction: A powerful collaboration platform combined with a chat app to easily connect with your co-workers and improve the productivity & collaboration for businesses of all sizes.
Introduction: CellMax is a liquid biopsy company focused on cancer screening with a proprietary technology for detecting precancer and cancer cells in a single blood sample.
(K&L Gates, Partner)
Certified Public Accountant
Demo Day & Wine Gathering
– 內湖 堤頂大道一段一號1F (Office & Demo Day Venue)
– 2F-1, No7, Sec 1, Dunhua S. Rd, Taipei
– 10F, No 25, Sec 1, Dunhua S. Rd, Taipei
– 1F, No1, Sec 1, Tiding Blvd, Taipei (Office & Demo Day Venue)
廈門辦公室 | 福建省厦门市思明区仙岳路623号台湾山庄2楼
India Hyderabad office | 101,Sai Krishna Enclave, Plot No:75, Jaagruti Colony,Survey No.70,Kondapur,Hyderabad – 500084
成都辦公室 | 成都市高新区天府软件园E1-8楼